Sponsors (77)
Introduced June 4, 2025 by Frank Pallone · Last progress June 4, 2025
The bill boosts insurance coverage, transparency, and scientific standards to speed and stabilize vaccine access—particularly for children—while narrowing executive flexibility, creating tight review deadlines that could strain scientific review, and introducing modest new federal costs.
Insured individuals (including Medicaid beneficiaries and people with chronic conditions) will have required coverage of ACIP‑recommended immunizations without cost‑sharing, increasing access to recommended vaccines.
The bill codifies evidence‑based, peer‑reviewed standards and transparency for vaccine recommendations and for changes to the Vaccine Injury Table, which should increase public confidence, consistency, and scientific rigor in vaccine policy and safety decisions.
Children and adolescents enrolled in the Vaccines for Children (VFC) program gain a clear statutory vaccine list to guide purchases and administration, improving timely access to pediatric vaccines.
The Department of Health and Human Services (Secretary) would be required to adopt ACIP recommendations unless explicitly overturned with a published scientific rationale, reducing executive discretion and flexibility in emergency or policy contexts.
Short statutory deadlines (e.g., 90 days) for committee review could pressure ACIP and manufacturers, risking rushed reviews or incomplete evidence synthesis for complex vaccines.
Rapid public reporting and required congressional notifications when recommendations aren't adopted (within 48 hours) may politicize scientific decision‑making and invite fast political pressure on experts.
Based on analysis of 3 sections of legislative text.
Codifies ACIP into statute, requires HHS to adopt ACIP vaccine recommendations unless disproven by preponderant peer-reviewed evidence, and raises the evidentiary standard for changes to the Vaccine Injury Table.
Codifies the Advisory Committee on Immunization Practices (ACIP) into statute and requires the HHS Director to adopt ACIP vaccine recommendations unless the Director publishes a written, evidence-based reasoned determination that the recommendation is not supported by the preponderance of the best available, peer-reviewed scientific evidence; if the Director does not adopt a recommendation, the Director must notify specified Congressional committees within 48 hours. The bill also requires the ACIP to consider newly licensed vaccines, breakthrough-designated vaccines, and vaccines for declared public health emergencies on an accelerated timeline, and it imposes a scientific-evidence standard for any removal or modification of entries on the Vaccine Injury Table under the National Vaccine Injury Compensation Program.